{"id":25764,"date":"2019-04-26T12:19:10","date_gmt":"2019-04-26T10:19:10","guid":{"rendered":"https:\/\/wordpress-783423-2671269.cloudwaysapps.com\/?p=25764"},"modified":"2025-01-29T13:43:46","modified_gmt":"2025-01-29T12:43:46","slug":"26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna","status":"publish","type":"post","link":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/","title":{"rendered":"<span id=\"2019\" class=\"Postdate\">April 26, 2019<\/span> | Dermapharm to expand capacities at  its main production site in Brehna"},"content":{"rendered":"<h1>Corporate news<\/h1>\n<p><a class=\"zur\u00fcckbutton\" href=\"https:\/\/cometis.de\/en\/publication-archive-dermapharm\">to the archive<\/a><\/p>\n<p>&nbsp;<\/p>\n<h1>Dermapharm to expand capacities at its main production site in Brehna<\/h1>\n<ul>\n<li>Topping out ceremony for new logistics center in Brehna near Leipzig<\/li>\n<li>Expansion of the production site by 12,400 m\u00b2<\/li>\n<li>Total investments for new construction of around EUR 11 million<\/li>\n<li>Commitment to Germany as a business location and creation of the logistical prerequisites for the continued growth of the Dermapharm Group<\/li>\n<\/ul>\n<p><strong>Gr\u00fcnwald, April 26, 2019 \u2013 Dermapharm Holding SE (\u201cDermapharm\u201d), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas in Germany with a growing international presence, celebrated the topping-out ceremony for the new logistics <\/strong>center<strong> of its subsidiary <\/strong>mibe<strong> GmbH Arzneimittel in Brehna near Leipzig on April 25, 2019. The new building expands the existing production site by around 12,400 m\u00b2 to a total of over 50,000 m\u00b2 and thus creates the logistical prerequisites for the continued growth of the Dermapharm Group.<\/strong><\/p>\n<p>The individual divisions of the company, from in-house product development and pharmaceutical production to dispatch and sales in the spatial arrangement, are efficiently interlinked at the Brehna production site. The new building will now make an important contribution to this and will also create the conditions for further expanding production. In Brehna, a wide variety of pharmaceutical dosage forms, including sterile pharmaceuticals such as ampoules and freeze-drying products, tablets, coated tablets, capsules, ointments, solutions, drops and sprays, can be manufactured under one roof. This technological diversity makes the Brehna production site unique. Well-known branded pharmaceuticals manufactured in Brehna include Dekristol\u00ae, Solacutan\u00ae and Prednisolut\u00ae, for example, but also many products known especially in Central Germany such as Panthenol eye ointment, Simagel\u00ae and Summavit\u00ae.<\/p>\n<p>Mibe GmbH Arzneimittel is Dermapharm&#8217;s largest production site. Around 90% of the extensive product portfolio &#8220;Made in Germany&#8221; is manufactured here and at the other German sites of the group.<\/p>\n<p>\u201cWe deliberately chose Brehna for the expansion of our production and logistics capacities. We are continuing to invest in the region in which we have been deeply rooted with our subsidiary mibe for 16 years now. We are thus also committed to Germany as a production location and guarantee our customers the highest manufacturing quality,\u201d said Dr. Hans-Georg Feldmeier, CEO of Dermapharm, in commenting on the capacity expansion.<\/p>\n<p>The ground-breaking ceremony took place in September 2018. The completion of the logistics center is scheduled for September 2019. The investments for the new building total around EUR 11 million. The project will be supported with EUR 1.65 million in subsidies from the state of Saxony-Anhalt. More than 570 employees are currently employed in Brehna, including around 20 trainees. The new dispatch hall offers potential for further jobs and apprenticeships in the area of logistics.<\/p>\n<p><strong>Images of the construction process:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/cometis.de\/wp-content\/uploads\/2019\/04\/Neubau_1.jpg\">Image construction 1<\/a><\/li>\n<li><a href=\"https:\/\/cometis.de\/wp-content\/uploads\/2019\/04\/Neubau_2.jpg\">Image construction 2<\/a><\/li>\n<li><a href=\"https:\/\/cometis.de\/wp-content\/uploads\/2019\/04\/Neubau_3.jpg\">Image construction 3<\/a><\/li>\n<li><a href=\"https:\/\/cometis.de\/wp-content\/uploads\/2019\/04\/Neubau_4.jpg\">Image construction 4<\/a><\/li>\n<li><a href=\"https:\/\/cometis.de\/wp-content\/uploads\/2019\/04\/Neubau_5.jpg\">Image construction 5<\/a><\/li>\n<\/ul>\n<p><strong>Investor Relations<\/strong><\/p>\n<p>Britta Hamberger<br \/>\nPhone: +49 (0)89 \u2013 64186-233<br \/>\nFax: +49 (0)89 \u2013 64186-165<br \/>\ne-mail: ir@dermapharm.com<\/p>\n<p>cometis AG<br \/>\nClaudius Krause<br \/>\nPhone: +49 (0)611 \u2013 205855-28<br \/>\nFax: +49 (0)611 \u2013 205855-66<br \/>\ne-mail: ir@dermapharm.com<\/p>\n<p><strong>Company profile<\/strong><\/p>\n<p><strong>Dermapharm \u2013 Pharmaceutical Excellence &#8220;Made in Germany&#8221;<\/strong><\/p>\n<p>Dermapharm is a leading manufacturer of patent-free branded pharmaceuticals for selected markets in Germany. Founded in 1991, the company is based in Gr\u00fcnwald near Munich and has its main manufacturing facility in Brehna near Leipzig. The company\u2019s integrated business model comprises in-house development, in-house production and distribution of pharmaceuticals and other healthcare products for specifically targeted markets by a medical and pharmaceutical sales force. Dermapharm holds approximately 900 marketing authorizations (Arzneimittelzulassungen) for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. This assortment makes the company unique. In addition to Germany, the company\u2019s core markets also include Austria and Switzerland. The company plans to further expand its international presence. Dermapharm\u2019s business model also includes a parallel import business, which operates under the \u201caxicorp\u201d brand. Based on revenues, Dermapharm was among the top five parallel import companies in Germany in 2018. In the &#8220;Herbal Extracts&#8221; segment, Dermapharm has access to the growth market for plant pharmaceuticals through the Spanish company Euromed S.A., one of the leading manufacturer of plant extracts and plant-based active ingredients.<\/p>\n<p>With a consistent development strategy and numerous successful product and company acquisitions over the past 25 years, Dermapharm has continuously optimized its business and provided external growth impulses in addition to organic growth. Dermapharm intends to continue this profitable growth course in the future. The company is focusing on a three-pillar strategy: in-house development of new products, increase of its international footprint and further acquisitions.<\/p>\n<div class=\"leseprobe-archiv\"><a title=\"Post as PDF\" href=\"https:\/\/cometis.de\/wp-content\/uploads\/2019\/04\/e_190426_CN_Derma_ToppingOut.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Post as PDF<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00bb\tTopping out ceremony for new logistics center in Brehna near Leipzig<br \/>\n\u00bb\tExpansion of the production site by 12,400 m\u00b2<br \/>\n\u00bb\tTotal investments for new construction of around EUR 11 million<br \/>\n\u00bb\tCommitment to Germany as a business location and creation of the logistical prerequisites for the continued growth of the Dermapharm Group <\/p>\n","protected":false},"author":2,"featured_media":98872,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[215,90,212],"tags":[260],"class_list":["post-25764","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dermapharm-corporate-news-en","category-news-en","category-uncategorized","tag-2019-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.2 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>April 26, 2019 | Dermapharm to expand capacities at its main production site in Brehna - cometis AG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"April 26, 2019 | Dermapharm to expand capacities at its main production site in Brehna\" \/>\n<meta property=\"og:description\" content=\"\u00bb Topping out ceremony for new logistics center in Brehna near Leipzig \u00bb Expansion of the production site by 12,400 m\u00b2 \u00bb Total investments for new construction of around EUR 11 million \u00bb Commitment to Germany as a business location and creation of the logistical prerequisites for the continued growth of the Dermapharm Group\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/\" \/>\n<meta property=\"og:site_name\" content=\"cometis AG\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-26T10:19:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-29T12:43:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cometis.de\/wp-content\/uploads\/2024\/12-old\/Cometis-Mobile-Logo-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"171\" \/>\n\t<meta property=\"og:image:height\" content=\"31\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Assistenz cometis AG\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Assistenz cometis AG\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/\"},\"author\":{\"name\":\"Assistenz cometis AG\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/#\\\/schema\\\/person\\\/5359bae3178840cd846706150aa69cd1\"},\"headline\":\"April 26, 2019 | Dermapharm to expand capacities at its main production site in Brehna\",\"datePublished\":\"2019-04-26T10:19:10+00:00\",\"dateModified\":\"2025-01-29T12:43:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/\"},\"wordCount\":738,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/icon_newsroom.svg\",\"keywords\":[\"2019\"],\"articleSection\":[\"Dermapharm Corporate News\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/\",\"url\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/\",\"name\":\"April 26, 2019 | Dermapharm to expand capacities at its main production site in Brehna - cometis AG\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/icon_newsroom.svg\",\"datePublished\":\"2019-04-26T10:19:10+00:00\",\"dateModified\":\"2025-01-29T12:43:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/icon_newsroom.svg\",\"contentUrl\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/icon_newsroom.svg\",\"width\":172,\"height\":172},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/category\\\/uncategorized\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"April 26, 2019 | Dermapharm to expand capacities at its main production site in Brehna\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/\",\"name\":\"cometis AG\",\"description\":\"Deutschlands f\u00fchrende Investor Relations Agentur\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/#organization\",\"name\":\"cometis AG\",\"alternateName\":\"Deutschlands f\u00fchrende Investor Relations Agentur\",\"url\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2024\\\/12-old\\\/Cometis-Mobile-Logo-1.png\",\"contentUrl\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2024\\\/12-old\\\/Cometis-Mobile-Logo-1.png\",\"width\":171,\"height\":31,\"caption\":\"cometis AG\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/cometis-ag\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/cometisAG\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/#\\\/schema\\\/person\\\/5359bae3178840cd846706150aa69cd1\",\"name\":\"Assistenz cometis AG\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g\",\"caption\":\"Assistenz cometis AG\"},\"url\":\"https:\\\/\\\/www.cometis.de\\\/en\\\/author\\\/assistenz-cometis-ag\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"April 26, 2019 | Dermapharm to expand capacities at its main production site in Brehna - cometis AG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/","og_locale":"en_US","og_type":"article","og_title":"April 26, 2019 | Dermapharm to expand capacities at its main production site in Brehna","og_description":"\u00bb Topping out ceremony for new logistics center in Brehna near Leipzig \u00bb Expansion of the production site by 12,400 m\u00b2 \u00bb Total investments for new construction of around EUR 11 million \u00bb Commitment to Germany as a business location and creation of the logistical prerequisites for the continued growth of the Dermapharm Group","og_url":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/","og_site_name":"cometis AG","article_published_time":"2019-04-26T10:19:10+00:00","article_modified_time":"2025-01-29T12:43:46+00:00","og_image":[{"width":171,"height":31,"url":"https:\/\/www.cometis.de\/wp-content\/uploads\/2024\/12-old\/Cometis-Mobile-Logo-1.png","type":"image\/png"}],"author":"Assistenz cometis AG","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Assistenz cometis AG","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/#article","isPartOf":{"@id":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/"},"author":{"name":"Assistenz cometis AG","@id":"https:\/\/www.cometis.de\/en\/#\/schema\/person\/5359bae3178840cd846706150aa69cd1"},"headline":"April 26, 2019 | Dermapharm to expand capacities at its main production site in Brehna","datePublished":"2019-04-26T10:19:10+00:00","dateModified":"2025-01-29T12:43:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/"},"wordCount":738,"publisher":{"@id":"https:\/\/www.cometis.de\/en\/#organization"},"image":{"@id":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cometis.de\/wp-content\/uploads\/2022\/06\/icon_newsroom.svg","keywords":["2019"],"articleSection":["Dermapharm Corporate News","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/","url":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/","name":"April 26, 2019 | Dermapharm to expand capacities at its main production site in Brehna - cometis AG","isPartOf":{"@id":"https:\/\/www.cometis.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/#primaryimage"},"image":{"@id":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cometis.de\/wp-content\/uploads\/2022\/06\/icon_newsroom.svg","datePublished":"2019-04-26T10:19:10+00:00","dateModified":"2025-01-29T12:43:46+00:00","breadcrumb":{"@id":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/#primaryimage","url":"https:\/\/www.cometis.de\/wp-content\/uploads\/2022\/06\/icon_newsroom.svg","contentUrl":"https:\/\/www.cometis.de\/wp-content\/uploads\/2022\/06\/icon_newsroom.svg","width":172,"height":172},{"@type":"BreadcrumbList","@id":"https:\/\/www.cometis.de\/en\/26-april-2019-dermapharm-to-expand-capacities-at-its-main-production-site-in-brehna\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cometis.de\/en\/"},{"@type":"ListItem","position":2,"name":"Uncategorized","item":"https:\/\/www.cometis.de\/en\/category\/uncategorized\/"},{"@type":"ListItem","position":3,"name":"April 26, 2019 | Dermapharm to expand capacities at its main production site in Brehna"}]},{"@type":"WebSite","@id":"https:\/\/www.cometis.de\/en\/#website","url":"https:\/\/www.cometis.de\/en\/","name":"cometis AG","description":"Deutschlands f\u00fchrende Investor Relations Agentur","publisher":{"@id":"https:\/\/www.cometis.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cometis.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cometis.de\/en\/#organization","name":"cometis AG","alternateName":"Deutschlands f\u00fchrende Investor Relations Agentur","url":"https:\/\/www.cometis.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cometis.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.cometis.de\/wp-content\/uploads\/2024\/12-old\/Cometis-Mobile-Logo-1.png","contentUrl":"https:\/\/www.cometis.de\/wp-content\/uploads\/2024\/12-old\/Cometis-Mobile-Logo-1.png","width":171,"height":31,"caption":"cometis AG"},"image":{"@id":"https:\/\/www.cometis.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/cometis-ag\/","https:\/\/www.youtube.com\/user\/cometisAG"]},{"@type":"Person","@id":"https:\/\/www.cometis.de\/en\/#\/schema\/person\/5359bae3178840cd846706150aa69cd1","name":"Assistenz cometis AG","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g","caption":"Assistenz cometis AG"},"url":"https:\/\/www.cometis.de\/en\/author\/assistenz-cometis-ag\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cometis.de\/en\/wp-json\/wp\/v2\/posts\/25764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cometis.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cometis.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cometis.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cometis.de\/en\/wp-json\/wp\/v2\/comments?post=25764"}],"version-history":[{"count":0,"href":"https:\/\/www.cometis.de\/en\/wp-json\/wp\/v2\/posts\/25764\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cometis.de\/en\/wp-json\/wp\/v2\/media\/98872"}],"wp:attachment":[{"href":"https:\/\/www.cometis.de\/en\/wp-json\/wp\/v2\/media?parent=25764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cometis.de\/en\/wp-json\/wp\/v2\/categories?post=25764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cometis.de\/en\/wp-json\/wp\/v2\/tags?post=25764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}